From BioHealth Investor
by H.S. Ayoub
BioHealth Investor
Stem cell stocks gained big time on Thursday as the new U.S. congress was set to take helm. The new Domocratic agenda promises to ease restrictions on embryonic stem cell research funding imposed by the Bush administration.
While Bush is expected to veto the new legislation, critics believe there is enough push in the Senate to over-ride the veto.
It is exptected that under a Democratic environment biotech stocks in general should perform well over the next few years, especially contraversial areas such as embryonic stem cell research.
Shares of Geron (GERN), StemCells (STEM), Aastrom (ASTM), Thermogenesis (KOOL), LifeCell (LIFC), Advanced Cell Technology (ACTC), Viacell (VIAC). Cryo-Cell (CCEL), and Cord Bloog America (CBAI) all gained on the day.
Aastrom, StemCells, Cord Blood America and Advanced Cell Technology all gained by double digit percentage points.
http://www.biohealthinvestor.com/
Essential Tips for Investing: Sponsored
A financial advisor can help you understand the advantages and disadvantages of investment properties. Finding a qualified financial advisor doesn’t have to be hard. SmartAsset’s free tool matches you with up to three financial advisors who serve your area, and you can interview your advisor matches at no cost to decide which one is right for you. If you’re ready to find an advisor who can help you achieve your financial goals, get started now.
Investing in real estate can diversify your portfolio. But expanding your horizons may add additional costs. If you’re an investor looking to minimize expenses, consider checking out online brokerages. They often offer low investment fees, helping you maximize your profit.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Editors' Picks
